Physiopathology of Behavioral Addictions and Biomarkers (MiRACle)
Physiopathology of Behavioral Addictions and Biomarkers: microRNAs Implication - MiRACle : a Pilot Study.
The goal of this observational study is to evaluate the expression of miR-10a-5p in the blood in patients with sexual addiction or food addiction. The main question it aims to answer is : To determine whether adults patients with SA or FA exhibit a distinct blood miR-10a-5p expression profile compared with matched healthy controls.
For all participants, one blood sample will be collected.
調査の概要
研究の種類
入学 (推定)
連絡先と場所
研究連絡先
- 名前:Pr Caroline Victorri-Vigneau
- 電話番号:02.40.84.76.20
- メール:marie.bronnec@chu-nantes.fr
研究場所
-
-
-
Nantes、フランス
- Nantes University Hospital
-
コンタクト:
- Gaëlle CHALLET
- 電話番号:02.40.84.76.20
- メール:gaelle.bouju@chu-nantes.fr
-
-
参加基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
サンプリング方法
調査対象母集団
Patients with food or sexual addiction, compared with age- and sex-matched healthy controls with no current addictive disorder.
説明
Inclusion criteria
For patients with FA:
- Male and females ≥ 18 years old
- Already in care or newly initiating care
- Participating to EVALADD cohort
- Current diagnosis of FA
- Oral consent provided
- Affiliated with French social security system or beneficiary from such system
For healthy controls matched to patients with FA:
- Male and females ≥ 18 years old
- Oral consent provided
- Affiliated with French social security system or beneficiary from such system
For patients with SA:
- Male ≥ 18 years old
- Already in care or newly initiating care
- Participating to EVALADD cohort
- Current diagnosis of SA
- Oral consent provided
- Affiliated with French social security system or beneficiary from such system
For healthy controls matched to patients with SA:
- Male ≥ 18 years old
- Oral consent provided
- Affiliated with French social security system or beneficiary from such system
Exclusion Criteria :
For patients with FA:
- Presence of a current diagnosis of SA
- Presence of any current addictive disorder (substance [except tobacco] use disorders, gambling disorder, gaming disorder)
- Presence of any current instable psychiatric disorder (requiring the initiation or adapation of medication)
- Pregnancy or breastfeeding woman
- Trusteeship or curatorship
- Major cognitive impairment
- Not fluent in French
For patients with SA:
- Presence of a current diagnosis of FA
- Presence of any current addictive disorder (substance [except tobacco] use disorders, gambling disorder, gaming disorder)
- Presence of any current instable psychiatric disorder (requiring the initiation or adapation of medication)
- Trusteeship or curatorship
- Major cognitive impairment
- Not fluent in French
For healthy controls:
- Without a current diagnosis of FA
- Without a current diagnosis of SA
- Presence of any current addictive disorder (substance [except tobacco] use disorders, gambling disorder, gaming disorder)
- Presence of any current instable psychiatric disorder (requiring the initiation or adapation of medication)
- Pregnancy or breastfeeding woman
- Trusteeship or curatorship
- Major cognitive impairment
- Not fluent in French
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 観測モデル:CASE_CONTROL
- 時間の展望:PROSPECTIVE
コホートと介入
グループ/コホート |
介入・治療 |
|---|---|
|
Patients with addiction
Patients with food addiction (FA) or sexual addiction |
One blood sample wiil be collected into a 10mL K2EDTA BD Vacutainer® tube |
|
Healthy controls
Healthy controls matched on sex and age to patients with food addiction or sexual addiction |
One blood sample wiil be collected into a 10mL K2EDTA BD Vacutainer® tube |
この研究は何を測定していますか?
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Blood miR-10a-5p expression
時間枠:3 months
|
The concentration of each miR-enriched fraction will be determined by spectrophotometric between patients with SA or FA and matched healthy controls. |
3 months
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Blood additional circulating miRs expression
時間枠:3 months
|
The concentration of circulating miRs fraction will be determined by spectrophotometric between patients with SA or FA and matched healthy controls. |
3 months
|
|
Clinical Characteristics
時間枠:3 months
|
Association between blood expression levels of circulating miRs and age |
3 months
|
|
Clinical Characteristics
時間枠:3 months
|
Association between blood expression levels of circulating miRs and sex |
3 months
|
|
Clinical Characteristics
時間枠:3 months
|
Association between blood expression levels of circulating miRs and duration of addiction |
3 months
|
|
Clinical Characteristics
時間枠:3 months
|
Association between blood expression levels of circulating miRs and severity of addiction |
3 months
|
|
Clinical Characteristics
時間枠:3 months
|
Association between blood expression levels of circulating miRs and tobacco-use |
3 months
|
|
Clinical Characteristics
時間枠:3 months
|
Association between blood expression levels of circulating miRs and psychiatric disorders |
3 months
|
協力者と研究者
研究記録日
主要日程の研究
研究開始 (推定)
一次修了 (推定)
研究の完了 (推定)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。